Mesenchymal Stem Cell Therapy for Knee Osteoarthritis
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The study is a multicentered, randomized, double-blinded, placebo-controlled study conducted
on the unilateral knee of 120 patients. The study compares the effectiveness of an injection
of a mesenchymal stem cell preparation from autologous bone marrow aspirate (BMA) to a
corticosteroid control for knee osteoarthritis. WOMAC, VAS pain scores, and MRI will be used
for assessment. The study will be conducted at 3 sites in the United States.